These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25837757)

  • 1. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
    Xu Z; Chen H; Liu D; Huo J
    Medicine (Baltimore); 2015 Apr; 94(13):e663. PubMed ID: 25837757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanoma.
    Wu BJ; Zhou ZP; Li WP; Ding W; Wu YZ; Zhou ZW; Zhang RQ; Liu QF; Jiang H
    Tumour Biol; 2014 Jan; 35(1):123-7. PubMed ID: 23907575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.
    Xiao W; Wang J; Li H; Guan W; Xia D; Yu G; Xiao H; Lang B; Ma X; Liu J; Zhang X; Ye Z; Xu H
    J Urol; 2013 Jul; 190(1):291-301. PubMed ID: 23391467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
    Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
    Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
    Moon JW; Choi JH; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Kim GJ; Park SH
    Cancer Genet; 2015 May; 208(5):261-70. PubMed ID: 26002729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.
    Chen H; Xu Z
    Dis Markers; 2015; 2015():345080. PubMed ID: 26693202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma.
    Kanda M; Nomoto S; Okamura Y; Hayashi M; Hishida M; Fujii T; Nishikawa Y; Sugimoto H; Takeda S; Nakao A
    Mol Carcinog; 2011 Aug; 50(8):571-9. PubMed ID: 21268132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
    Cheng YY; Jin H; Liu X; Siu JM; Wong YP; Ng EK; Yu J; Leung WK; Sung JJ; Chan FK
    Br J Cancer; 2008 Dec; 99(12):2083-7. PubMed ID: 18985039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
    Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
    Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
    Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
    Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
    Kano H; Takayama T; Midorikawa Y; Nagase H
    Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of LRRC3B in colorectal cancer.
    Tian XQ; Zhang Y; Sun D; Zhao S; Xiong H; Fang J
    Scand J Gastroenterol; 2009; 44(1):79-84. PubMed ID: 18815942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
    Karibe T; Fukui H; Sekikawa A; Shiratori K; Fujimori T
    J Pathol; 2008 Sep; 216(1):32-42. PubMed ID: 18543267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
    Li DJ; Feng ZC; Li XR; Hu G
    World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
    Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
    Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASGRF1 Hypermethylation, a Putative Biomarker of Colorectal Cancer.
    Chen H; Xu Z; Yang B; Zhou X; Kong H
    Ann Clin Lab Sci; 2018 Jan; 48(1):3-10. PubMed ID: 29530990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.